Business Context and Reporting Period
Company: PHOTRONICS, INC.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 30, 1996
Business Overview: Photronics manufactures photomasks for the semiconductor industry. The reporting period reflects significant growth driven by capacity expansion and two major acquisitions: the photomask operations of Plessey Semiconductors Limited (UK) and the Litomask Division of CSEM (Switzerland).
Key Financial Metrics
| Metric | Three Months Ended Apr 30, 1996 |
Six Months Ended Apr 30, 1996 |
Six Months Ended Apr 30, 1995 |
|---|---|---|---|
| Net Sales | $40.5 million | $75.2 million | $56.2 million |
| Net Income | $5.3 million | $9.9 million | $7.1 million |
| Diluted EPS | $0.44 | $0.82 | $0.68 |
| Operating Income | $8.1 million | $15.1 million | $10.8 million |
| Operating Margin | 20.1% | 20.1% | 19.2% |
| Cash & Equivalents | $32.9 million (Balance Sheet) | Decreased $19.0 million during the six-month period | |
| Long-Term Debt | $1.8 million | No significant change | |
| Working Capital | $41.5 million | Derived from Current Assets ($69.1M) - Current Liabilities ($27.7M) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 34.9% for the quarter and 33.7% for the six-month period compared to the prior year. Growth was driven by increased shipments from existing facilities, the Beta Squared subsidiary, and the inclusion of new European and Colorado acquisitions.
- Cost Structure: Cost of sales rose 34.7% (quarter) and 32.2% (six months), tracking with volume increases. However, cost of sales as a percentage of net sales improved slightly to 61.2% and 61.3% respectively, aided by higher capacity utilization and a favorable product mix of complex photomasks.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 32.7% (quarter) and 31.2% (six months) due to foreign operations and staffing growth. R&D expenses increased 33.1% (quarter) and 34.2% (six months) to support development of high-end technologies (phase shift, optical proximity correction).
- Profitability: Net income increased 37.9% for the quarter and 39.9% for the six-month period. The effective tax rate increased slightly to 37.8% and 38.1% due to a larger portion of income subject to the 35% federal rate.
Guidance, Outlook, and Risks
- Capital Expenditures: The company has outstanding commitments of approximately $65.1 million for capital expenditures, including new facilities in Texas and Singapore. Management expects fixed operating costs to rise with capacity expansion but anticipates matching these with continued revenue growth.
- Liquidity: Cash and cash equivalents decreased by $19.0 million during the six-month period, primarily due to $18.6 million in capital expenditures and $8.5 million in acquisition costs. Management believes current resources, bank credit lines, and access to debt/equity markets are sufficient for foreseeable needs.
- Acquisition Integration: Recent acquisitions (Plessey and Litomask) are being integrated. The Plessey operation is currently leased and intended to be relocated to an independent facility in Manchester, UK, within one year.
- Risks: The filing notes that lower margins at recently acquired operations offset some efficiency gains. Continued demand for complex photomasks is cited as a positive driver.
Investor Verification Checklist
- Capital Commitments: Verify the $65.1 million in outstanding capital expenditure commitments and the funding strategy for new Texas and Singapore facilities.
- Acquisition Performance: Monitor the integration and margin performance of the Plessey (UK) and Litomask (Switzerland) operations, which were noted to have lower margins initially.
- Cash Burn Rate: Review the sustainability of the $19.0 million cash decrease against the $5.7 million operating cash flow generated in the six-month period.
- Share Count: Note the increase in weighted average shares outstanding (to ~12.0 million) due to prior public offerings and stock-based compensation, which impacts EPS dilution.